S. Sibéril

发表

Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory Fc gamma R functions.

W. Fridman, M. Hogarth, D. Bourel, 2006, Clinical immunology.

Molecular aspects of human FcgammaR interactions with IgG: functional and therapeutic consequences.

W. Fridman, C. Dutertre, E. Stura, 2006, Immunology letters.

Future Prospects in Antibody Engineering and Therapy

J. Teillaud, S. Sibéril, 2004 .

Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: a mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies.

É. Oksenhendler, C. Sautès-Fridman, S. Kaveri, 2011, Journal of autoimmunity.

Human iNKT and MAIT cells exhibit a PLZF-dependent proapoptotic propensity that is counterbalanced by XIAP.

A. Fischer, C. Picard, O. Lantz, 2013, Blood.

Sialylated therapeutic IgG: a sweet remedy for inflammatory diseases?

S. Kaveri, J. Dimitrov, J. Bayry, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Intravenous Immunoglobulin: An Update on the Clinical Use and Mechanisms of Action

S. Kaveri, S. Lacroix-Desmazes, M. Kazatchkine, 2007, Journal of Clinical Immunology.

Intravenous Immunoglobulins in Autoimmune and Inflammatory Diseases

S. Kaveri, S. Lacroix-Desmazes, M. Kazatchkine, 2007, Annals of the New York Academy of Sciences.

Effective control of Staphylococcus aureus lung infection despite tertiary lymphoid structure disorganisation

P. Burgel, J. Teillaud, S. Sibéril, 2020, European Respiratory Journal.

Impact of Depleting Therapeutic Monoclonal Antibodies on the Host Adaptive Immunity: A Bonus or a Malus?

C. Deligne, J. Teillaud, S. Sibéril, 2017, Front. Immunol..

Recovery of central memory and naive peripheral T cells in Follicular Lymphoma patients receiving rituximab-chemotherapy based regimen

F. Petitprez, A. Toubert, P. Brice, 2019, Scientific Reports.

Human X-linked variable immunodeficiency caused by a hypomorphic mutation in XIAP in association with a rare polymorphism in CD40LG.

A. Fischer, L. Fugger, E. López-Granados, 2011, Blood.

Activation of Human Peripheral IgM+ B Cells Is Transiently Inhibited by BCR-Independent Aggregation of FcγRIIB1

C. Sautès-Fridman, W. Fridman, A. Varin, 2008, The Journal of Immunology.

Fcγ Receptor-like Activity of Hepatitis C Virus Core Protein*

J. Lavergne, F. Roohvand, P. Maillard, 2004, Journal of Biological Chemistry.

Longitudinal and Integrative Biomodeling of Effector and Memory Immune Compartments after Inactivated Influenza Vaccination

A. Samri, C. Katlama, F. Carrat, 2013, The Journal of Immunology.

VaccinationCompartments after Inactivated Influenza Effector and Memory Immune Longitudinal and Integrative Biomodeling of

Malka, A. Samri, C. Katlama, 2013 .

Isolation and characterization of anti-FcgammaRIII (CD16) llama single-domain antibodies that activate natural killer cells.

C. Sautès-Fridman, G. Béhar, P. Chames, 2008, Protein engineering, design & selection : PEDS.

Isolation and characterization of anti-FcγRIII (CD16) llama single-domain antibodies that activate natural killer cells

C. Sautès-Fridman, G. Béhar, P. Chames, 2007 .

Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?

C. Sautès-Fridman, W. Fridman, S. Sibéril, 2022, Seminars in immunology.

Rescuing CD4+CD25+ regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapy.

S. Kaveri, D. Tough, J. Bayry, 2007, Drug discovery today.

FcγR: The key to optimize therapeutic antibodies?

W. Fridman, C. Dutertre, J. Teillaud, 2007 .

Tight Interplay Between Therapeutic Monoclonal Antibodies and the Tumour Microenvironment in Cancer Therapy.

S. Sibéril, Aditi Varthaman, Q. Riller, 2020, Advances in experimental medicine and biology.

Keeping the memory of influenza viruses.

D. Duffy, B. Combadière, S. Sibéril, 2010, Pathologie-biologie.

Autophagy Modulation by Viral Infections Influences Tumor Development

I. Cremer, M. Alifano, S. Sibéril, 2021, Frontiers in Oncology.

Effect of zinc on human IgG1 and its FcγR interactions.

W. Fridman, E. Stura, R. Ménez, 2012, Immunology letters.

Presence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patients

A. Toubert, C. Deligne, P. Brice, 2019, Cancer Immunology, Immunotherapy.

FcgammaR: The key to optimize therapeutic antibodies?

W. Fridman, C. Dutertre, J. Teillaud, 2007, Critical reviews in oncology/hematology.

Immature and mature antibodies as defenders against cancer

J. Dimitrov, S. Sibéril, Robin Lacombe, 2022, Cellular & Molecular Immunology.

Exploring the Role of Tertiary Lymphoid Structures Using a Mouse Model of Bacteria-Infected Lungs.

P. Burgel, J. Teillaud, S. Sibéril, 2018, Methods in molecular biology.

Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.

S. Kaveri, S. Lacroix-Desmazes, M. Kazatchkine, 2007, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

I. Cremer, M. Alifano, S. Sibéril, 2022, Cancers.

Comparative study of the anti-inflammatory effect of two intravenous immunoglobulin preparations manufactured by different processes.

S. Kaveri, M. Kazatchkine, J. Duong van Huyen, 2006, Immunology letters.

[Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].

S. Kaveri, S. Lacroix-Desmazes, M. Kazatchkine, 2007, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

Unraveling the complex interplay between anti-tumor immune response and autoimmunity mediated by B cells and autoantibodies in the era of anti-checkpoint monoclonal antibody therapies

C. Sautès-Fridman, S. Sibéril, Pierre-Emmanuel Joubert, 2024, Frontiers in Immunology.